Facing Stronger Global Competition And A Patent Cliff, Eisai Explores New Business Model
This article was originally published in PharmAsia News
Executive Summary
TOKYO - Faced with strengthening global competition involving rival drugs and the approaching expiration of a patent on a blockbuster product, Japan's Eisai is overhauling its decade-old business model
You may also be interested in...
Eisai Plans R&D Structure Revamp, Hoping To Turn The Development Tide
TOKYO - Eisai CEO Haruo Naito unveiled plans to revamp the company's research and development structure in hopes of having his employees produce better results, Naito told analysts Feb. 27 in Tokyo
PharmAsia News Business Bulletin
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).
PharmAsia News Business Bulletin
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).